WT1 and acute myeloid leukemia: Although other markers and techniques are preferred for MRD measurement (reviewed by [3,4]), WT1 messenger RNA (mRNA) levels can be used as a marker for MRD and a prognostic factor for relapse in AML if no other markers are available [31].